Log In
BCIQ
Print this Print this
 

DT-1154

  Manage Alerts
Collapse Summary General Information
Company Dual Therapeutics LLC
DescriptionOral small molecule protein phosphatase 2 (PPP2CA; PP2A) activator
Molecular Target Protein phosphatase 2 (PPP2CA) (PP2A)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration-resistant prostate cancer (CRPC) that has progressed after treatment with anti-androgens and/or chemotherapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today